| 标题 |
Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet Oncology 作者:Hope S. Rugo; Florence Lerebours; Eva Ciruelos; Pamela Drullinsky; Manuel Ruíz‐Borrego; et al 出版日期:2024-12-01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)